Patents by Inventor Imtiaz Chaudry

Imtiaz Chaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orally administrable solid dosage form
    Patent number: 5914128
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 22, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Use of mometasone furoate for treating lower airway passage and lung diseases
    Patent number: 5889015
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: March 30, 1999
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating upper airway passage diseases
    Patent number: 5837699
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: November 17, 1998
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of GM-CSF as a vaccine adjuvant
    Patent number: 5679356
    Abstract: The present invention is a method for enhancing the immune response of a mammal to a vaccine by administering to such a mammal an effective amount of GM-CSF in conjunction with a vaccine. The present invention further provides for pharmaceutical compositions containing an effective amount of GM-CSF and a vaccine. Kits containing GM-CSF and a vaccine are also disclosed.
    Type: Grant
    Filed: January 5, 1995
    Date of Patent: October 21, 1997
    Assignee: Schering Corporation
    Inventors: Eric M. Bonnem, Imtiaz A. Chaudry, Elliot Stupak
  • Non-chlorofluorocarbon aerosol formulations
    Patent number: 5474759
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons for oral and/or nasal administration are described. The formulations comprise 1,1,1,2,3,3,3-heptafluoropropane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations are also described.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: December 12, 1995
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Sustained release oral suspensions
    Patent number: 5186930
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: February 16, 1993
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry
  • Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine
    Patent number: 5100675
    Abstract: Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: March 31, 1992
    Assignee: Schering Corporation
    Inventors: Wing-Kee P. Cho, Winston A. Vadino, Imtiaz A. Chaudry
  • Sustained release oral suspensions
    Patent number: 4999189
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: November 14, 1988
    Date of Patent: March 12, 1991
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry
  • Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
    Patent number: 4990535
    Abstract: Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.
    Type: Grant
    Filed: May 3, 1989
    Date of Patent: February 5, 1991
    Assignee: Schering Corporation
    Inventors: Wing-Kee P. Cho, Winston A. Vadino, Imtiaz A. Chaudry
  • Insoluble copper-alpha interferon complex
    Patent number: 4871538
    Abstract: An insoluble copper-alpha interferon complex useful for injectable pharmaceutical compositions is disclosed.
    Type: Grant
    Filed: July 13, 1987
    Date of Patent: October 3, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Martin Zupon, Imtiaz Chaudry
  • Zinc-protamine-alpha interferon complex
    Patent number: 4853218
    Abstract: An insoluble zinc-protamine alpha interferon complex useful as an injectable sustained release dosage form for administering alpha interferon is disclosed.
    Type: Grant
    Filed: February 24, 1987
    Date of Patent: August 1, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Michael A. Zupon, Imtiaz A. Chaudry
  • Stable oleaginous gel
    Patent number: 4851220
    Abstract: Stable oleaginous gels comprising water-in-oil emulsions in gels are disclosed. Sustained release injectable pharmaceutical formulations comprising such oleaginous gels are also disclosed, in particular such formulations comprising interferon.
    Type: Grant
    Filed: November 26, 1986
    Date of Patent: July 25, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Michael A. Zupon, Imtiaz A. Chaudry
  • Stable injectable labetalol formulation
    Patent number: 4328213
    Abstract: An injectable formulation for the pharmaceutically acceptable acid addition salts of labetalol, its isomers and mixtures thereof is provided which has enhanced stability properties.
    Type: Grant
    Filed: November 28, 1979
    Date of Patent: May 4, 1982
    Assignee: Schering Corporation
    Inventors: Varda Ecker, Yogendra M. Shah, Imtiaz A. Chaudry